";s:4:"text";s:3771:" Epub 2013 Dec 20.Clin Pharmacokinet. IEEE Engineering in Medicine and Biology Society 2008;47(7):463-74. doi: 10.2165/00003088-200847070-00003.
Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. Methaneethorn J, Chamnansua M, Kaewdang N, Lohitnavy M. BACKGROUND: Verapamil is a calcium channel blocker commonly used in treatments of hypertension. Table 1. Clipboard, Search History, and several other advanced features are temporarily unavailable.
Clipboard, Search History, and several other advanced features are temporarily unavailable. 2004 Nov 1;94(9):1140-6. doi: 10.1016/j.amjcard.2004.07.080.Ther Clin Risk Manag. Evaluation of potential pharmacodynamic interaction was based on the behavioral tests: elevated plus maze (EPM) test and the Vogel conflict test (VCT).
A pharmacokinetic drug-drug interaction model of simvastatin and verapamil in humans.
Simvastatin study . Unable to load your collection due to an error
2014;2014:5715-8. doi: 10.1109/EMBC.2014.6944925.Methaneethorn J, Chaiwong K, Pongpanich K, Sonsingh P, Lohitnavy M.Conf Proc IEEE Eng Med Biol Soc.
A number of drugs are known to inhibit OATP1b1 (eg, clarithromycin, erythromycin, cyclosporine, ketoconazole, many protease inhibitors, gemfibrozil) and are known to increase simvastatin concentrations. Pharmacokinetic drug interaction study with saxagliptin and simvastatin, diltiazem extended-release, or ketoconazole in healthy subjects—study design. However, there is no such dose limitation for atorvastatin for patients receiving amlodipine.
2014;10:17-26. doi: 10.2147/TCRM.S55512.
Subject demographics and baseline characteristics of the three studies of saxagliptin and simvastatin, diltiazem extended-release, and ketoconazole. Studies were conducted on male Wistar Han rats treated with simvastatin (2.5, 5, 10, 20 mg/kg) for 4–6 weeks, and/or diazepam (2.5, 5, 10 mg/kg) administered once on the day of the study. 5 Note that many OATP1b1 inhibitors are also CYP3A4 inhibitors, which provides the opportunity for a dual mechanism drug interaction with simvastatin. 2018 Nov;33(11):1868-1876. doi: 10.1007/s11606-018-4415-9. In patients with coronary heart disease (CHD) or at high risk of CHD, Simvastatin tablets ca… Please enable it to take advantage of the complete set of features! Clarithromycin is a commonly used macrolide antibiotics and a potent inhibitor of CYP3A4. Methaneethorn J, Chaiwong K, Pongpanich K, Sonsingh P, Lohitnavy M. BACKGROUND: Simvastatin is a HMG-CoA reductase Inhibitor and a substrate of CYP3A4. When co-administered with simvastatin, clarithromycin … 2014;10:17-26. doi: 10.2147/TCRM.S55512.
Name must be less than 100 characters This site needs JavaScript to work properly. 2014;2014:5703-6. doi: 10.1109/EMBC.2014.6944922.Am J Cardiol.
A pharmacokinetic drug-drug interaction model of simvastatin and clarithromycin in humans. 2014;2014:5715-8. doi: 10.1109/EMBC.2014.6944925.Lohitnavy M, Methaneethorn J, Chiang-Ngernthanyakool R, Tongpeng W, Chan-Im D, Phaohorm S.Conf Proc IEEE Eng Med Biol Soc. Unable to load your collection due to an error This site needs JavaScript to work properly.